$ROCK
GIBRALTAR INDUSTRIES, INC.

2024 Q2 Form 10-Q Financial Statement

#000091256224000028 Filed on May 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $353.0M $292.5M
YoY Change -3.26% -0.26%
Cost Of Revenue $257.1M $208.2M
YoY Change -3.0% -3.77%
Gross Profit $95.87M $84.32M
YoY Change -3.97% 9.6%
Gross Profit Margin 27.16% 28.83%
Selling, General & Admin $53.40M $52.25M
YoY Change -0.47% 9.85%
% of Gross Profit 55.7% 61.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.753M $6.663M
YoY Change -1.14% -2.5%
% of Gross Profit 7.04% 7.9%
Operating Expenses $53.40M $52.24M
YoY Change -0.47% 9.85%
Operating Profit $42.47M $32.07M
YoY Change -8.04% 9.2%
Interest Expense $1.495M $750.0K
YoY Change -214.3% -150.3%
% of Operating Profit 3.52% 2.34%
Other Income/Expense, Net -$347.0K $1.021M
YoY Change -168.17% 157.18%
Pretax Income $43.62M $33.51M
YoY Change 3.17% 18.5%
Income Tax $11.42M $8.561M
% Of Pretax Income 26.18% 25.55%
Net Earnings $32.20M $24.95M
YoY Change 4.8% 18.23%
Net Earnings / Revenue 9.12% 8.53%
Basic Earnings Per Share
Diluted Earnings Per Share $1.05 $0.81
COMMON SHARES
Basic Shares Outstanding 30.47M shares 30.44M shares
Diluted Shares Outstanding 30.79M shares 30.79M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $179.1M $146.7M
YoY Change 861.83% 1856.32%
Cash & Equivalents $179.1M $146.7M
Short-Term Investments
Other Short-Term Assets $18.91M $15.21M
YoY Change 3.23% -20.04%
Inventory $134.5M $137.9M
Prepaid Expenses
Receivables $259.4M $231.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $591.9M $530.7M
YoY Change 27.84% 23.92%
LONG-TERM ASSETS
Property, Plant & Equipment $108.3M $150.6M
YoY Change -17.43% 39.85%
Goodwill $511.6M $511.8M
YoY Change -0.07% -0.16%
Intangibles $121.6M $124.3M
YoY Change -7.85% -7.78%
Long-Term Investments
YoY Change
Other Assets $2.471M $2.464M
YoY Change 349.27% 248.51%
Total Long-Term Assets $785.1M $789.1M
YoY Change 1.22% 1.14%
TOTAL ASSETS
Total Short-Term Assets $591.9M $530.7M
Total Long-Term Assets $785.1M $789.1M
Total Assets $1.377B $1.320B
YoY Change 11.17% 9.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $140.9M $127.5M
YoY Change -9.38% -1.64%
Accrued Expenses $85.10M $82.81M
YoY Change 2.84% 23.4%
Deferred Revenue $59.50M $53.26M
YoY Change 8.5% 24.07%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $285.5M $263.6M
YoY Change -2.58% 9.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $26.07M $58.97M
YoY Change -32.11% 210.06%
Total Long-Term Liabilities $26.07M $58.97M
YoY Change -45.9% -14.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $285.5M $263.6M
Total Long-Term Liabilities $26.07M $58.97M
Total Liabilities $311.6M $379.7M
YoY Change -19.76% 23.04%
SHAREHOLDERS EQUITY
Retained Earnings $795.7M $763.5M
YoY Change 17.04% 17.62%
Common Stock $343.0K $343.0K
YoY Change 0.29% 0.59%
Preferred Stock
YoY Change
Treasury Stock (at cost) $155.8M $155.8M
YoY Change 1.41% 15.44%
Treasury Stock Shares
Shareholders Equity $975.7M $940.2M
YoY Change
Total Liabilities & Shareholders Equity $1.377B $1.320B
YoY Change 11.17% 9.22%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $32.20M $24.95M
YoY Change 4.8% 18.23%
Depreciation, Depletion And Amortization $6.753M $6.663M
YoY Change -1.14% -2.5%
Cash From Operating Activities $36.47M $53.18M
YoY Change -52.04% 39.78%
INVESTING ACTIVITIES
Capital Expenditures $4.341M $4.366M
YoY Change 40.3% 99.36%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $350.0K $0.00
YoY Change -100.0%
Cash From Investing Activities -$3.991M -$4.366M
YoY Change 28.99% 166.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities -13.00K -1.434M
YoY Change -99.98% -96.92%
NET CHANGE
Cash From Operating Activities 36.47M 53.18M
Cash From Investing Activities -3.991M -4.366M
Cash From Financing Activities -13.00K -1.434M
Net Change In Cash 32.47M 47.38M
YoY Change 182.48% -568.61%
FREE CASH FLOW
Cash From Operating Activities $36.47M $53.18M
Capital Expenditures $4.341M $4.366M
Free Cash Flow $32.13M $48.82M
YoY Change -55.96% 36.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
208118000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
216338000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
84388000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
76929000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
52652000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47559000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
31736000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29370000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
750000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1491000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1021000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
397000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33507000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
28276000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8561000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7177000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
24946000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
21099000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.82
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.68
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.81
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.68
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30572000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30897000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30793000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31024000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
24946000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
21099000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-964000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-107000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23982000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20992000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146665000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99426000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5578000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5572000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
230971000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
224550000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
137878000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
120503000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
15205000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
17772000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
530719000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
462251000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
108028000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
107603000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
42592000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44918000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
511797000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
513383000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
124257000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
125980000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2464000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2316000 usd
CY2024Q1 us-gaap Assets
Assets
1319857000 usd
CY2023Q4 us-gaap Assets
Assets
1256451000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
127533000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
92124000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
82805000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
88719000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
53261000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44735000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
263599000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
225578000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
57106000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
57103000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33793000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35989000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
25174000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22783000 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34266000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34266000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34219000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34219000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
343000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
342000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
335259000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
332621000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
763457000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
738511000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3078000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2114000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3797000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3778000 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
155796000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
154362000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
940185000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
914998000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1319857000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1256451000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
24946000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
21099000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6663000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6834000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2639000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1594000 usd
CY2024Q1 rock Noncash Project Abandonment Costs Reversal Of Costs
NoncashProjectAbandonmentCostsReversalOfCosts
-72000 usd
CY2023Q1 rock Noncash Project Abandonment Costs Reversal Of Costs
NoncashProjectAbandonmentCostsReversalOfCosts
-63000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-51000 usd
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1691000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1023000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6950000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18004000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17231000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1586000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-453000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2536000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
35455000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
23077000 usd
CY2024Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
5587000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1586000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53181000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38045000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4366000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2190000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-554000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4366000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1636000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
50000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
11000000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1434000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7509000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1434000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-46509000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-142000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-11000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
47239000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10111000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99426000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17608000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
146665000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7497000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
914998000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
24946000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-964000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2639000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1434000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
940185000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
822099000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
21099000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-107000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1594000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1929000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
7369000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
835387000 usd
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
194343000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
178087000 usd
CY2024Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
42206000 usd
CY2023Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
52035000 usd
CY2024Q1 rock Contracts Receivable Gross Current
ContractsReceivableGrossCurrent
236549000 usd
CY2023Q4 rock Contracts Receivable Gross Current
ContractsReceivableGrossCurrent
230122000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5578000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5572000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
230971000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
224550000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5572000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
20000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
14000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5578000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7700000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3900000 usd
CY2024Q1 rock Contract With Customer Liability Including New Contract Revenue Recognized
ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized
27700000 usd
CY2023Q1 rock Contract With Customer Liability Including New Contract Revenue Recognized
ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized
18700000 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
84524000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
77489000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
12400000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
9508000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
47811000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
42942000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
144735000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
129939000 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
6857000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
9436000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
137878000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
120503000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
513383000 usd
CY2024Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-1110000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-476000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
511797000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
133200000 usd
CY2024Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
133200000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
136127000 usd
CY2024Q1 rock Total Acquired Intangible Assets Accumulated Amortization
TotalAcquiredIntangibleAssetsAccumulatedAmortization
64170000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
152931000 usd
CY2023Q4 rock Total Acquired Intangible Assets Accumulated Amortization
TotalAcquiredIntangibleAssetsAccumulatedAmortization
79251000 usd
CY2024Q1 rock Acquired Intangible Assets Total
AcquiredIntangibleAssetsTotal
188427000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
64170000 usd
CY2023Q4 rock Acquired Intangible Assets Total
AcquiredIntangibleAssetsTotal
205231000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
79251000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2718000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2766000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
7926000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
10485000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
9897000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
7639000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
7281000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
7232000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1700000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1700000 usd
CY2023Q1 rock Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options To Be Converted
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsToBeConverted
147572 shares
CY2023Q1 rock Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Units To Be Converted Percentage Of Target Amount
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsUnitsToBeConvertedPercentageOfTargetAmount
2.000
CY2024Q1 rock Accrued Equity Based Compensation
AccruedEquityBasedCompensation
23000000 usd
CY2023Q4 rock Accrued Equity Based Compensation
AccruedEquityBasedCompensation
20000000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
9139000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
6251000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
929000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-88000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
10068000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
6163000 usd
CY2024Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
407000 usd
CY2024Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
-72000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
335000 usd
CY2023Q1 rock Business Exit Costs Recoveries
BusinessExitCostsRecoveries
675000 usd
CY2023Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
-63000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
612000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
335000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
612000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
6725000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
2417000 usd
CY2024Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
407000 usd
CY2023Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
675000 usd
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
553000 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
1321000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
6579000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
1771000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2024Q1 us-gaap Revenues
Revenues
292506000 usd
CY2023Q1 us-gaap Revenues
Revenues
293267000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
31736000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29370000 usd
CY2024Q1 us-gaap Assets
Assets
1319857000 usd
CY2023Q4 us-gaap Assets
Assets
1256451000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8561000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7177000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.256
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.254
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
24946000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
21099000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30572000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30897000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30572000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30897000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
221000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
127000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30793000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31024000 shares
CY2024Q1 us-gaap Revenues
Revenues
292506000 usd
CY2023Q1 us-gaap Revenues
Revenues
293267000 usd

Files In Submission

Name View Source Status
0000912562-24-000028-index-headers.html Edgar Link pending
0000912562-24-000028-index.html Edgar Link pending
0000912562-24-000028.txt Edgar Link pending
0000912562-24-000028-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q12024exhibit311.htm Edgar Link pending
q12024exhibit312.htm Edgar Link pending
q12024exhibit321.htm Edgar Link pending
q12024exhibit322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rock-20240331.htm Edgar Link pending
rock-20240331.xsd Edgar Link pending
rock-20240331_g1.jpg Edgar Link pending
Show.js Edgar Link pending
rock-20240331_def.xml Edgar Link unprocessable
rock-20240331_htm.xml Edgar Link completed
rock-20240331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
rock-20240331_lab.xml Edgar Link unprocessable
rock-20240331_pre.xml Edgar Link unprocessable